During the Axel Springer Awards, Elon Musk described mRNA technology as a "software program" for the body that could eventually reverse aging or alter genetics. The discussion shifts to Bill Gates, noting that his foundation's wealth continues to grow through strategic investments. The hosts question whether these billionaires are the ultimate decision-makers or merely high-level managers for a global elite.
